Newsletter Archive
-
04.03.26 -- New Podcast Episodes: Regenerative Skin Therapy, Orally Available Biologics, Regulatory Flexibility In CGT, and More
4/3/2026
04/03/26 Bioprocess Online Newsletter
-
04.03.26 -- Scaling Regenerative Medicine Production With PolarityBio's Nikolai Sopko
4/3/2026
04/03/26 Bioprocess Online Newsletter
-
04.03.26 -- STREAM Edition: Trends In FDA FY 2025 Warning Letters
4/3/2026
04/03/26 Bioprocess Online Newsletter
-
04.02.26 -- Automation That Delivers: From Liquid Handling To Cell Lines
4/2/2026
04/02/26 Bioprocess Online Newsletter
-
04.02.26 -- FDA's 483 Playbook: What It Means For Pharma Outsourcing — And What It Doesn't Address
4/2/2026
04/02/26 Bioprocess Online Newsletter
-
04.01.26 -- FDA's Final NDC Rule Provides A 900-Year Supply Of Label Codes
4/1/2026
04/01/26 Bioprocess Online Newsletter
-
03.31.26 -- Watch: 60 Seconds on Atypical Optimization + More
3/31/2026
03/31/26 Bioprocess Online Newsletter
-
03.31.26 -- February 2026 — CDMO Opportunities And Threats Report
3/31/2026
03/31/26 Bioprocess Online Newsletter
-
03.30.26 -- Rethink Your Equipment Strategy Before Your Next Capital Decision
3/30/2026
03/30/26 Bioprocess Online Newsletter
-
03.30.26 -- The Importance Of Process Locks To Align Upstream And Downstream
3/30/2026
03/30/26 Bioprocess Online Newsletter